Intellectual Property: Patent Litigation - Germany
What the team is known for
Hoffmann Eitle possesses a deep bench of IP specialists benefiting from market-leading patent prosecution capabilities. The team is highly popular with clients from the life sciences industry, particularly clients based in Japan and the USA, and frequently handles international patent portfolios and patent opposition proceedings. The law firm also assists clients with nullity actions and revocation proceedings. Its expertise extends to patent litigation, acting for both claimants and defendants.
Strengths
"The team are very responsive and come up with creative answers. They know the technical stuff well and the firm is a big German powerhouse."
"The lawyers are business-focused, pragmatic and know what is useful in matters."
"Hoffmann Eitle provides sound and sage advice on brand protection and enforcement matters."
"The team is able to quickly understand very complex technical and legal situations."
"Hoffmann Eitle provides excellent and proactive support."
Work highlights
Hoffmann Eitle represented Match Group in a nullity action before the Federal Patent Court and supported the client in parallel patent infringement proceedings.
Foreign desks
The firm has several Japanese-speaking lawyers who assist clients with standard-essential patent cases and advise Japanese companies on patent infringement and nullity actions. Key contacts at the firm for Japanese matters include Dirk Schüßler-Langeheine and Clemens Steins.
Notable practitioners
Thorsten Bausch boasts extensive experience in patent prosecutions within the life sciences space. He also frequently represents clients before the EPO. "He is amazing, a go-to-lawyer in Europe for patent opposition. He is a superb litigator."
Joseph Taormino has experience in patent applications and portfolio management. His practice predominantly focuses on the life sciences field.
Peter Klusmann is a well-recognised practitioner in the intellectual property space. He often acts for clients from the chemistry and biotechnology sectors.